Deutsche Bank’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-884
| Closed | -$63.5K | – | 3731 |
|
|
2023
Q2 | $63.5K | Hold |
884
| – | – | ﹤0.01% | 3423 |
|
|
2023
Q1 | $59.6K | Hold |
884
| – | – | ﹤0.01% | 3505 |
|
|
2022
Q4 | $27.4K | Hold |
884
| – | – | ﹤0.01% | 3713 |
|
|
2022
Q3 | $24K | Hold |
884
| – | – | ﹤0.01% | 3739 |
|
|
2022
Q2 | $39K | Sell |
884
-318
| -26% | -$14.6K | ﹤0.01% | 3825 |
|
|
2022
Q1 | $76K | Sell |
1,202
-503
| -30% | -$36K | ﹤0.01% | 3684 |
|
|
2021
Q4 | $143K | Buy |
1,705
+67
| +4% | +$7.52K | ﹤0.01% | 3535 |
|
|
2021
Q3 | $266K | Sell |
1,638
-90
| -5% | -$14.6K | ﹤0.01% | 3416 |
|
|
2021
Q2 | $261K | Sell |
1,728
-41
| -2% | -$6.91K | ﹤0.01% | 3629 |
|
|
2021
Q1 | $307K | Sell |
1,769
-125
| -7% | -$23.8K | ﹤0.01% | 3399 |
|
|
2020
Q4 | $302K | Buy |
1,894
+400
| +27% | +$67K | ﹤0.01% | 3225 |
|
|
2020
Q3 | $238K | Sell |
1,494
-2,281
| -60% | -$412K | ﹤0.01% | 3123 |
|
|
2020
Q2 | $748K | Buy |
3,775
+2,887
| +325% | +$530K | ﹤0.01% | 2402 |
|
|
2020
Q1 | $138K | Sell |
888
-31
| -3% | -$3.13K | ﹤0.01% | 3117 |
|
|
2019
Q4 | $70K | Buy |
919
+475
| +107% | +$41.4K | ﹤0.01% | 3761 |
|
|
2019
Q3 | $43K | Sell |
444
-753
| -63% | -$87.6K | ﹤0.01% | 4012 |
|
|
2019
Q2 | $157K | Sell |
1,197
-2,622
| -69% | -$360K | ﹤0.01% | 3968 |
|
|
2019
Q1 | $577K | Sell |
3,819
-4,208
| -52% | -$655K | ﹤0.01% | 3357 |
|
|
2018
Q4 | $1.3M | Buy |
8,027
+4,644
| +137% | +$922K | ﹤0.01% | 2703 |
|
|
2018
Q3 | $872K | Sell |
3,383
-561
| -14% | -$141K | ﹤0.01% | 3435 |
|
|
2018
Q2 | $900K | Buy |
3,944
+59
| +2% | +$11.2K | ﹤0.01% | 3503 |
|
|
2018
Q1 | $547K | Buy |
+3,885
| New | +$587K | ﹤0.01% | 3659 |
|
|
2017
Q2 | – | Sell |
-35
| Closed | -$3K | – | 4961 |
|
|
2017
Q1 | $3K | Buy |
+35
| New | +$3.91K | ﹤0.01% | 4744 |
|
|
2016
Q4 | – | Sell |
-20
| Closed | -$2K | – | 4935 |
|
|
2016
Q3 | $2K | Buy |
20
+16
| +400% | +$1.66K | ﹤0.01% | 4816 |
|
|
2016
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5199 |
|
|
2016
Q1 | $0 | Sell |
4
-501
| -99% | -$43.5K | ﹤0.01% | 5185 |
|
|
2015
Q4 | $56K | Buy |
505
+485
| +2,425% | +$66K | ﹤0.01% | 4342 |
|
|
2015
Q3 | $2K | Sell |
20
-155
| -89% | -$20.7K | ﹤0.01% | 5107 |
|
|
2015
Q2 | $21K | Buy |
175
+150
| +600% | +$20.4K | ﹤0.01% | 4893 |
|
|
2015
Q1 | $6K | Buy |
+25
| New | +$5.14K | ﹤0.01% | 4871 |
|
Other funds holding CTSO
CM
Deutsche Bank's CTSO Position: Q3 2023 in Review
Deutsche Bank sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 884 shares — an estimated $63.5K sold.
Deutsche Bank first reported a position in CTSO in Q1 2015 and held it in 30 quarters. The position peaked at $1.3M in Q4 2018. 51 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.
- Deutsche Bank reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
- Deutsche Bank sold 884 Cytosorbents Corp shares in Q3 2023, an estimated $63.5K.
- Deutsche Bank first reported a position in Cytosorbents Corp in Q1 2015 and held it in 30 quarters.
- Deutsche Bank's Cytosorbents Corp position peaked at $1.3M in Q4 2018.
- 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.
Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.